Biomedical Engineering Reference
In-Depth Information
31. Candeliere GA, Glorieux FH, Prud'homme J,
St-Arnaud R (1995) Increased expression of the c-fos
proto-ocogene in bone from patients with fi brous
dysplasia. N Engl J Med 332:1546-1551.
32. Carano RA, Filvaroff EH (2003) Angiogenesis and
bone repair. Drug Discov Today 8:980-989.
33. Carlevaro MF, Cermelli S, Cancedda R, Descalzi
Cancedda F (2000) Vascular endothelial growth
factor (VEGF) in cartilage neovascularization and
chondrocyte differentiation: auto-paracrine role
during endochondral bone formation. J Cell Sci
113:59-69.
34. Carvalho RS, Einhorn TA, Lehmann W, Edgar C,
Al-Yamani A, Apazidis A, Pacicca D, Clemens TL,
Gerstenfeld LC (2004) The role of angiogenesis in a
murine tibial model of distraction osteogenesis.
Bone 34:849-861.
35. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM,
Rosen V, Wang EA, Wozney JM (1990) Identifi cation
of transforming growth factor beta family members
present in bone-inductive protein purifi ed from
bovine bone. Proc Natl Acad Sci 87:9843-9847.
36. Chen S, Guttridge DC, Tang E, Shi S, Guan K, Wang
CY (2001) Suppression of tumor necrosis factor-
mediated apoptosis by nuclear factor kappaB-
independent bone morphogenetic protein/Smad
signaling. J Biol Chem 276:39259-39263.
37. Childs LM, Paschalis EP, Xing L, Dougall WC, Ander-
son D, Boskey AL, Puzas JE, Rosier RN, O'Keefe RJ,
Boyce BF, Schwarz EM (2002) In vivo RANK signal-
ing blockade using the receptor activator of NF-
kappaB:Fc effectively prevents and ameliorates wear
debris-induced osteolysis via osteoclast depletion
without inhibiting osteogenesis. J Bone Miner Res
17:192-199.
38. Cho T-J, Gerstenfeld LC, Einhorn TA (2002)
Differential temporal expression of members of
the transforming growth factor beta superfamily
during murine fracture healing. J Bone Miner Res
17:513-520.
39. Cho T-J, Lehmann W, Edgar C, Sadeghi C, Hou A,
Einhorn TA, Gerstenfeld LC (2003) Tumor necrosis
factor alpha activation of the apoptotic cascade
in murine articular chondrocytes is associated
with the induction of metalloproteinases and specifi c
pro-resorptive factors. Arthritis Rheum 48:2845-
2854.
40. Clauss IM, Gravallese EM, Darling JM (1993) In situ
hybridization studies suggest a role for the basic
region-leucine zipper protein hXBP-1 in exocrine
gland and skeletal development during mouse
embryogenesis. Dev Dyn 197:146 -156.
41. Constantinides PG, Taylor SM, Jones PA (1978) Phe-
notypic conversion of cultured mouse embryo cells
by aza pyrimidine nucleosides. Dev Biol 66:57-71.
42. Cullinane DM, Fredrick A, Eisenberg SR, Pacicca D,
Elman MV, Lee C, Salisbury K, Gerstenfeld LC,
Einhorn TA (2002) Induction of a neoarthrosis by
precisely controlled motion in an experimental mid-
femoral defect. J Orthop Res 20:579-586.
43. Danial NN, Korsmeyer SJ (2004) Cell death: critical
control points. Cell 116:205-219.
44. De Robertis EM, Larrain J, Oelgeschlager M, Wessely
O (2000) The establishment of Spemann's organizer
and patterning of the vertebrate embryo. Nat Rev
Genet 1:171-181.
45. Dealy CN, Roth A, Ferrari D, Brown AM, Kosher RA
(1993) Wnt-5a and Wnt-7a are expressed in the
developing chick limb bud in a manner suggesting
roles in pattern formation along the proximo
distal and dorsoventral axes. Mech Dev 43:175-
186.
46. Deckers MM, Karperien M, van der Bent C, Yamashita
T, Papapoulos SE, Lowik CW (2000) Expression of
vascular endothelial growth factors and their recep-
tors during osteoblast differentiation. Endocrinol-
ogy 141:1667-1674.
47. Deckers MM, van Bezooijen RL, van der Horst G,
Hoogendam J, van Der Bent C, Papapoulos SE, Lowik
CW (2002) Bone morphogenetic proteins stimulate
angiogenesis through osteoblast-derived vascular
endothelial growth factor A. Endocrinology 143:
1545-1553.
48. Dempster DW, Cosman F, Kurland ES, Zhou H,
Nieves J, Woelfert L, Shane E, Plavetic K, Muller R,
Bilezikian J, Lindsay R (2001) Effects of daily treat-
ment with parathyroid hormone on bone microar-
chitecture and turnover in patients with osteoporosis:
a paired biopsy study. J Bone Miner Res 16:1846-
1853.
49. Dosch R, Gawantka V, Delius H, Blumenstock C,
Niehrs C (1997) BMP-4 acts as a morphogen in dor-
soventral mesoderm patterning in Xenopus. Devel-
opment 124:2325-2334.
50. Dunstan CR, Boyce R, Boyce BF, Garrett IR, Izbicka
E, Burgess WH, Mundy GR (1999) Systemic adminis-
tration of acidic fi broblast growth factor (FGF-1)
prevents bone loss and increases new bone formation
in ovariectomized rats. J Bone Miner Res 14:953-
959.
51. Einhorn TA (1995) Enhancement of fracture healing.
J Bone Joint Surg 77:940-956.
52. Einhorn T, Lee C (2001) Bone regeneration: new fi nd-
ings and potential clinical applications. J Am Acad
Orthop Surg 9:157-165.
53. Einhorn TA, Majeska RJ, Mohaideen A, Kagel EM,
Bouxsein ML, Turek TJ, Wozney JM (2003) A single
percutaneous injection of recombinant human bone
morphogenetic protein-2 accelerates fracture repair.
J Bone Joint Surg Am 85-A:1425 -1435.
54. Einhorn TA, Majeska RJ, Rush EB, Levine PM,
Horowitz MC (1995) The expression of cytokine
activity by fracture callus. J Bone Miner Res 10:
1272-1281.
55. Eugster H-P, Muller M, LeHir M, Ryffel B (1998)
Immunodefi ciency of tumor necrosis factor and
lymophotoxin-alpha double defi cient mice. In:
Durum S, Muegge K, editors. Cytokine Knockouts.
Totowa: Humana Press, pp 103-118.
56. Farnum CE, Willsman NJ (1989) Cellular turnover at
the chondro-osseous junction of growth plate carti-
lage: analysis by serial sections at the light micro-
scopical level. J Orthop Res 7:654-666.
57. Feng JQ, Xing L, Zhang JH, Zhao M, Horn D, Chan J,
Boyce BF, Harris SE, Mundy GR, Chen D (2003)
NFkappaB specifi cally activates BMP-2 gene expres-
sion in growth plate chondrocytes in vivo and
in a chondrocyte cell line in vitro. J Biol Chem
278:29130-29135.
58. Ferguson C, Alpern E, Miclau T, Helms JA (1999)
Does adult fracture repair recapitulate embryonic
skeletal formation? Mech Dev 87:57-66.
